SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-311047
Filing Date
2011-11-14
Accepted
2011-11-14 16:31:48
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d238781d10q.htm 10-Q 310402
2 EX-31.1 d238781dex311.htm EX-31.1 9144
3 EX-31.2 d238781dex312.htm EX-31.2 9132
4 EX-32.1 d238781dex321.htm EX-32.1 3917
5 EX-32.2 d238781dex322.htm EX-32.2 3904
  Complete submission text file 0001193125-11-311047.txt   1356454

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cprx-20110930.xml EX-101.INS 152352
7 XBRL TAXONOMY EXTENSION SCHEMA cprx-20110930.xsd EX-101.SCH 10805
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20110930_cal.xml EX-101.CAL 23134
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20110930_def.xml EX-101.DEF 7466
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20110930_lab.xml EX-101.LAB 91819
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20110930_pre.xml EX-101.PRE 65830
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1370 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1370 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICAL PARTNERS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 111203173
SIC: 2834 Pharmaceutical Preparations